Cell Biotech Co., Ltd. (KOSDAQ:049960)

Cell Biotech Revenue

Cell Biotech had revenue of 14.60B KRW in the quarter ending March 31, 2026, with 30.00% growth. This brings the company's revenue in the last twelve months to 56.49B, up 17.44% year-over-year. In the year 2025, Cell Biotech had annual revenue of 53.13B with 6.44% growth.

• Revenue (ttm): 56.49B
• Revenue Growth: +17.44%
• P/S Ratio: 1.98
• Revenue / Employee: 559.35M
• Employees: 101
• Market Cap: 111.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	53.13B	3.21B	6.44%
Dec 31, 2024	49.91B	-3.87B	-7.20%
Dec 31, 2023	53.79B	3.26B	6.46%
Dec 31, 2022	50.53B	3.65B	7.79%
Dec 31, 2021	46.87B	1.29B	2.83%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error